Valuation: Zenotech Laboratories Limited

Market Cap 2.09B 21.92M 19.06M 17.74M 16.29M 30.75M 31.23M 209M 82.06M 1.04B 82.33M 80.52M 3.49B P/E 2024
43.5x
P/E 2025 56.5x
Enterprise Value 1.83B 19.13M 16.63M 15.47M 14.21M 26.83M 27.25M 182M 71.59M 909M 71.83M 70.25M 3.05B EV / Sales 2024
9.27x
EV / Sales 2025 7.42x
Free-Float
15.47%
Yield 2024 *
-
Yield 2025 -
07-28 Zenotech Laboratories Limited Reports Earnings Results for the First Quarter Ended June 30, 2026 CI
04-29 Zenotech Laboratories Limited Reports Earnings Results for the Fourth Quarter and Full Year Ended March 31, 2026 CI
01-23 Zenotech Laboratories Limited Announces Cessation of Chintan Jitendra Shah as Independent Director, Chairman of the Nomination and Remuneration Committee, Member of Audit Committee/ Stakeholders Relationship Committee and Reconstitution of Board Committees CI
01-23 Zenotech Laboratories Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2025 CI
31/10/25 Zenotech Laboratories Limited Reports Earnings Results for the Second Quarter and Six Months Ended September 30, 2025 CI
25/09/25 Zenotech Laboratories Limited Announces Updation of Address of the Registered Office CI
28/07/25 Zenotech Laboratories Limited Reports Earnings Results for the First Quarter Ended June 30, 2025 CI
30/03/25 Zenotech Laboratories Limited Announces Cessation of Kavita Rakesh Shah as Independent Director, with Effect from April 01, 2025 CI
28/01/25 Zenotech Laboratories Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2024 CI
23/10/24 Zenotech Laboratories Limited Appoints Dr. Sachin Laxmanappa Gavandare as Chief Executive Officer (Key Managerial Personnel) CI
23/10/24 Zenotech Laboratories Limited Reports Earnings Results for the Second Quarter and Six Months Ended September 30, 2024 CI
26/07/24 Zenotech Laboratories Limited Reports Earnings Results for the First Quarter Ended June 30, 2024 CI
17/05/24 Zenotech Laboratories Limited Announces Resignation of Devendra Chandrakant Shenvi Kenkre as Chief Executive Officer, Effective August 12, 2024 CI
1 day+0.20%
1 week+0.56%
1 month+0.75%
3 months+2.13%
6 months-0.49%
Current year-3.57%
1 week 43.5
Extreme 43.5
46.1
1 month 43.4
Extreme 43.4
48
Current year 33.55
Extreme 33.55
50.93
1 year 33.55
Extreme 33.55
60
3 years 33.55
Extreme 33.55
107.79
5 years 33.55
Extreme 33.55
107.79
10 years 12
Extreme 12
107.79
Manager TitleAgeSince
Chief Executive Officer - 22/10/2024
Director of Finance/CFO - 05/02/2014
Compliance Officer 46 10/03/2016
Director TitleAgeSince
Director/Board Member 58 07/07/2015
Chairman 67 -
Director/Board Member 42 26/01/2016
Change 5-day change 1-year change 3-year change Capi.($)
+0.20%+0.56%-21.43%-29.78% 28.48M
-0.53%-3.95%+55.23%+152.74% 1,024B
+0.21%-2.68%+55.61%+53.02% 618B
-2.51%-3.25%+32.76%+67.76% 443B
+0.06%-0.42%+37.53%+30.67% 349B
-0.14%-0.24%+34.41%+39.01% 297B
-0.69%-0.30%+11.55%+12.93% 264B
-7.37%-4.40%-2.54%-43.87% 209B
-0.64%+2.43%+30.52%+64.49% 208B
-0.82%+0.70%+15.96%+71.01% 162B
Average -1.22%-1.02%+24.96%+41.80% 357.38B
Weighted average by Cap. -0.99%-1.93%+39.24%+72.95%

Financials

2024 2025
Net sales 368M 3.86M 3.35M 3.12M 2.86M 5.41M 5.49M 36.78M 14.43M 183M 14.48M 14.16M 614M 391M 4.1M 3.56M 3.31M 3.04M 5.75M 5.83M 39.06M 15.33M 195M 15.38M 15.04M 653M
Net income 82.99M 869K 756K 703K 646K 1.22M 1.24M 8.29M 3.25M 41.31M 3.26M 3.19M 139M 56.13M 588K 511K 476K 437K 825K 838K 5.61M 2.2M 27.94M 2.21M 2.16M 93.7M
Net Debt -197M -2.06M -1.79M -1.67M -1.53M -2.89M -2.94M -19.67M -7.72M -98.01M -7.75M -7.58M -329M -267M -2.8M -2.43M -2.26M -2.08M -3.92M -3.99M -26.68M -10.47M -133M -10.51M -10.28M -446M
Logo Zenotech Laboratories Limited
Zenotech Laboratories Limited is an India-based pharmaceutical company. The Company is engaged in a business of manufacture and marketing of pharmaceuticals products. The Company is a pharmaceutical specialty generic injectables company engaged in the area of manufacturing oncology, biotechnology and general injectables products. The Company’s injectables product portfolio primarily serves niche therapy areas like oncology and anesthesiology. Its product includes granulocyte-colony stimulating factor (GCSF) and Granulocyte-macrophage colony-stimulating factor (GMCSF). The Company has a manufacturing facility at Turkapally village, Shamirpet Mandal, Telangana.
Employees
228
Date Price Change Volume
31/07/26 ₹44.54 +0.20% 4,017
30/07/26 ₹44.45 +0.14% 3,439
29/07/26 ₹44.39 +0.50% 7,140
28/07/26 ₹44.17 -2.06% 6,150
27/07/26 ₹45.10 +1.83% 7,662
  1. Stock Market
  2. Stocks
  3. ZENOTECH6 Stock